by John Conrad | Mar 19, 2020 | COVID, Member News
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company’s molecular test for novel coronavirus (COVID-19). Abbott is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA...
by John Conrad | Mar 18, 2020 | iBIO News
As we all watch for the latest developments on COVID-19, many of us from our homes, its important that we stay connected and updated on factual information as it relates to COVID-19 and our community. Podcasts can be a great source of information and also...
by John Conrad | Mar 12, 2020 | COVID, iBIO News
The Coronavirus is a serious global public health threat with information rapidly evolving. Innovative Life Sciences Companies are ramping up efforts to study the virus and develop solutions to prevent, diagnose and treat this deadly infectious disease. Visit...
by John Conrad | Mar 10, 2020 | COVID
Originally published on NBC 5 Chicago Inside Argonne National Laboratory in suburban DuPage County, researchers are getting their first glimpse of the proteins that make up the coronavirus in hopes of understanding how the virus works to combat it. “We gave priority...
by John Conrad | Mar 9, 2020 | COVID, Member News
AbbVie (NYSE:ABBV) today confirmed the company’s activities in the fight to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Kaletra/Aluvia (lopinavir/ritonavir) to determine its efficacy in the treatment...
